Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Total Non-Current Liabilities (2020 - 2021)

Historic Total Non-Current Liabilities for Protagonist Therapeutics (PTGX) over the last 2 years, with Q3 2021 value amounting to $43.4 million.

  • Protagonist Therapeutics' Total Non-Current Liabilities fell 875.95% to $43.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $43.4 million, marking a year-over-year decrease of 875.95%. This contributed to the annual value of $44.7 million for FY2020, which is N/A changed from last year.
  • Protagonist Therapeutics' Total Non-Current Liabilities amounted to $43.4 million in Q3 2021, which was down 875.95% from $46.7 million recorded in Q2 2021.
  • Protagonist Therapeutics' Total Non-Current Liabilities' 5-year high stood at $57.4 million during Q2 2020, with a 5-year trough of $38.6 million in Q1 2021.